Free Trial

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Sees Large Increase in Short Interest

Sartorius Aktiengesellschaft logo with Medical background

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,900 shares, a growth of 21.9% from the March 31st total of 3,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 39.0 days. Currently, 0.0% of the company's stock are sold short.

Wall Street Analysts Forecast Growth

Separately, DZ Bank raised shares of Sartorius Aktiengesellschaft from a "strong sell" rating to a "hold" rating in a research report on Thursday, April 17th.

Read Our Latest Stock Analysis on SARTF

Sartorius Aktiengesellschaft Stock Performance

Shares of SARTF remained flat at $210.47 during mid-day trading on Thursday. Sartorius Aktiengesellschaft has a 1-year low of $165.00 and a 1-year high of $252.54. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.02 and a quick ratio of 1.13. The company has a market capitalization of $7.20 billion, a PE ratio of 159.44 and a beta of 1.24. The stock's 50-day moving average price is $189.13 and its two-hundred day moving average price is $197.30.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last announced its earnings results on Wednesday, April 16th. The company reported $1.28 EPS for the quarter, meeting the consensus estimate of $1.28. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%. The company had revenue of $959.23 million for the quarter, compared to analyst estimates of $867.08 million.

Sartorius Aktiengesellschaft Company Profile

(Get Free Report)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

See Also

Should You Invest $1,000 in Sartorius Aktiengesellschaft Right Now?

Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.

While Sartorius Aktiengesellschaft currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines